These biomarkers could even facilitate evaluation of cancer risk in the general population because menstrual cycle homeostasis, which is an important driver of cell-nonautonomous mechanisms of cancer predisposition in BRCA1 mutation carriers, is the greatest known risk factor for the main histological subtypes of sporadic (non-familial) Müllerian carcinomas. This evidence concerns the gene BRCA1 and cancer.